Promotion of endogeneous remyelination in Multiple Sclerosis (Q41589680)

4 October 2017

1 reference

title

Promotion of endogenous remyelination in multiple sclerosis (English)

1 reference

4 October 2017

Promotion of endogeneous remyelination in Multiple Sclerosis (English)

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

15 November 2024

C. F. Lucchinetti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9291156

15 November 2024

J. H. Noseworthy

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9291156

15 November 2024

M. Rodriguez

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9291156

15 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9291156

15 November 2024

publication date

1 April 1997

1 reference

4 October 2017

April 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9291156

full work available at URL

15 November 2024

https://journals.sagepub.com/doi/pdf/10.1177/135245859700300202

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

Multiple Sclerosis Journal

15 November 2024

published in

1 reference

4 October 2017

1 reference

4 October 2017

1 reference

4 October 2017

page(s)

71-75

1 reference

Electron microscopic features of multiple sclerosis lesions

4 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300202

Oligodendrocyte injury is an early event in lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300202

Ultrastructure of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300202

Oligodendrocytes in the early course of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300202

Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300202

The T lymphocyte in experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300202

A monoclonal autoantibody which promotes central nervous system remyelination is highly polyreactive to multiple known and novel antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300202

Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300202

Glycolipids and transmembrane signaling in oligodendroglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300202

Immunosuppression promotes CNS remyelination in chronic virus‐induced demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300202

A monoclonal natural autoantibody that promotes remyelination suppresses central nervous system inflammation and increases virus expression after Theiler's virus-induced demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300202

Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300202

High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300202

Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300202

Open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300202

Intravenous immunoglobulin therapy in multiple sclerosis: progress from remyelination in the Theiler's virus model to a randomised, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300202

A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300202

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F135245859700300202

Regeneration of myelin in multiple sclerosis. The role of mesenchymal cells in such regeneration and in myelin formation in the peripheral nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

Remyelination in multiple sclerosis

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

Multiple sclerosis: remyelination of nascent lesions

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

Patterns of oligodendroglia pathology in multiple sclerosis

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

15 November 2024

Journal of Cell Science

257

Hall SM

1972

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

Failure of remyelination in areas of demyelination produced in the spinal cord of old rats

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

Chronic relapsing experimental autoimmune encephalomyelitis. treatment with combinations of myelin components promotes clinical and structural recovery

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

Demyelination and Remyelination in Murine Viral Encephalomyelitis

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

CRC Critical reviews in immunology

15 November 2024

325

Rodriguez M.

1987

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

Remyelination by oligodendrocytes stimulated by antiserum to spinal cord

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

Immunoglobulins promote remyelination in the central nervous system

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

Stimulation of myelin lipid synthesis in vitro by white matter antiserum in absence of complement

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

Stimulation of oligodendrocyte differentiation in culture by growth in the presence of a monoclonal antibody to sulfated glycolipid

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

Spontaneous CNS remyelination in beta 2 microglobulin-deficient mice following virus-induced demyelination.

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

Treatment of Guillain-Barré syndrome with high-dose gammaglobulin

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

MULTIPLE SCLEROSIS: THERAPEUTIC TRIALS OF CHLOROQUINE, SOLUBLE ASPIRIN, AND GAMMAGLOBULIN

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

First results of immunotherapy with immunoglobulin G in multiple sclerosis patients

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

Intravenous gamma globulin in progressive MS

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

High-dose intravenous immunoglobulin for multiple sclerosis

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

15 November 2024

835

vanEngelen Bgm

1992

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

A long-term prospective study of optic neuritis: evaluation of risk factors

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

Optic neuritis in children and its relationship to multiple sclerosis: a clinical study of 21 children

15 November 2024

1 reference

https://api.crossref.org/works/10.1177/135245859700300202

15 November 2024

Identifiers

0 references

1 reference